The antiproliferative effect of Quercetin in cancer cells is mediated via inhibition of the PI3K-Akt/PKB pathway

Anticancer Research

Volumn 26, Issue 2 A, 2006, Pages 1177-1181

  Gulati, Nicholas ^a   Laudet, Beatrice ^a   Zohrabian, Vahe Michael ^a   Murali, Raj ^a   Jhanwar Uniyal, Meena ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Akt PKB; LY 294002; PTEN; Quercetin

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4, 5 DIMETHYLTHIAZOL 2 YL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BROMINE DERIVATIVE; EPIDERMAL GROWTH FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; QUERCETIN; SERINE; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; GENE DELETION; HOMOZYGOSITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CHROMONES; ENZYME INHIBITORS; HUMANS; MORPHOLINES; PROTO-ONCOGENE PROTEINS C-AKT; QUERCETIN;

EID: 33645836334     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Cantley LC and Neel BG: New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96(8): 4240-4245, 1999.
2. Wang SI, Pue J, Li J, Bruce JN, Cairns P, Sidransky D and Parsons R: Somatic mutations of PTEN in glioblastoma multiforme. Cancer Res 57: 4183-4186, 1997.
3. Hyun T, Yam A, Pece S, Xie X, Zhang J, Miki T, Gutkind JS and Li W: Loss of PTEN expression leading to high Akt activation in human multiple myelomas. Blood 96(10): 3560-3568, 2000.
4. Careri M, Corradini C, Elviri L, Nicoletti I and Zagnoni I: Direct HPLC analysis of quercetin and trans-resveratrol in red wine, grape, and winemaking byproducts. J Agric Food Chem 51: 5226-5231, 2003.
5. Caltagirone S, Rossi C, Poggi A, Ranelletti FO, Natali PG, Brunetti M, Aiello FB and Piantelli M: Flavonoids apigenin and Qu inhibit melanoma growth and metastatic potential. Int J Cancer 87(4): 595-600, 2000.
6. Mahmoud NN, Carothers AM, Grunberger D, Bilinski RT, Churchill MR, Martucci C, Newmark HL and Bertagnolli MM: Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 21(5): 921-927, 2000.
7. Kaneuchi M, Sasaki M, Tanaka Y, Sakuragi N, Fujimoto S and Dahiya R: Qu regulates growth of Ishikawa cells through the suppression of EGF and cyclin D1. Int J Oncol 22: 159-164, 2003.
8. Walker EH, Pacold ME, Perisic O, Stephens L, Hawkins PT, Wymann MP and Williams RL: Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, Qu, myricetin, and staurosporine. Mol Cell 6(4): 909-919, 2000.
9. Vlahos CJ, Matter WF, Hui KY and Brown RF: A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem 269: 5241-5248, 1994.
10. Davies MA, Lu Y, Sano T, Fang X, Tang P, LaPushin R, Koul D, Bookstein R, Stokoe D, Yung WK, Mills GB and Steck PA: Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. Cancer Res 58(23): 5285-5290, 1998.
11. Li DM and Sun H: PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells. Proc Natl Acad Sci USA 95(26): 15406-15411, 1998.
12. Persad S, Troussard AA, McPhee TR, Mulholland DJ and Dedhar S: Tumor suppressor PTEN inhibits nuclear accumulation of beta-catenin and T cell/lymphoid enhancer factor 1-mediated transcriptional activation. J Cell Biol 153(6): 1161-1174, 2001.
13. Kip1 into cyclin E/CDK2 complexes. Cancer Res 59(70): 2318-2323, 1999.
14. Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK and Testa JR: AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene 23(34): 5853-5857, 2004.